News | October 02, 2013

Aplio 500 CV Used to Identify Leading Cause of Death in High School Athletes


October 2, 2013 — Sudden cardiac death (SCD) is the leading cause of death in high school-aged athletes. To determine if SCD can be prevented with a heart screening, The Christ Hospital Health Network (Cincinnati, Ohio), The University of Mississippi Medical Center and Cincinnati Children’s Hospital Medical Center partnered with USRowing and Toshiba America Medical Systems Inc. to conduct The Athlete Heart Research Study. Initial participants included volunteer high school rowers with more than two years of continuous practice who competed in the USRowing Youth National Championships, June 7 – 9, 2013, in Oak Ridge, Tenn.

“SCD affects one to two out of every 100,000 young adults, and high school athletes participating in a vigorous sport have a two to three times-greater risk,” said primary investigator Santosh Menon, M.D., cardiologist, The Christ Hospital Health Network. “While current recommendations only include a physical exam, we hope to identify what changes are considered normal for athletic hearts, versus the true presence of heart abnormalities, which may be the cause of SCD.”

Toshiba’s Aplio 500 CV was used to conduct heart tests on rowers using electrocardiogram (EKG) and echocardiogram (echo) screenings. With Toshiba’s 2D Wall Motion Tracking technology, the Aplio 500 CV provides visualization and quantitative analysis of myocardial wall motion with accuracy and reproducibility for earlier diagnosis.

For more information: www.medical.toshiba.com


Additional Content

News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Ultrasound Women's Health

Sept. 3, 2026 — Royal Philips has introduced the eV14-2v transvaginal transducer, expanding its obstetrics and ...

Time September 04, 2026
arrow
News | Breast Imaging

Aug. 20, 2026 — Candelis, Inc. has announced a collaboration with GE HealthCare to support the distribution of Candelis ...

Time August 24, 2026
arrow
News | Clinical Trials

Aug.12, 2026 — Mendaera Inc. has announced results from a peer-reviewed study showing that its FDA-cleared Focalist ...

Time August 17, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
Subscribe Now